chr11-61259252-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152718.2(VWCE):c.2291G>A(p.Ser764Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,610,484 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152718.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWCE | NM_152718.2 | c.2291G>A | p.Ser764Asn | missense_variant | 20/20 | ENST00000335613.10 | NP_689931.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWCE | ENST00000335613.10 | c.2291G>A | p.Ser764Asn | missense_variant | 20/20 | 1 | NM_152718.2 | ENSP00000334186.5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249024Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134694
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1458274Hom.: 0 Cov.: 31 AF XY: 0.00000552 AC XY: 4AN XY: 725010
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.2291G>A (p.S764N) alteration is located in exon 20 (coding exon 20) of the VWCE gene. This alteration results from a G to A substitution at nucleotide position 2291, causing the serine (S) at amino acid position 764 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at